Adult Hemoglobinopathy Testing Market Set to Reach USD$ 2.3 Billion by 2030: A 2.4% CAGR Forecast
The global Adult Hemoglobinopathy Testing Market, valued at USD$ 2 billion in 2023, is projected to expand to USD$ 2.3 billion by 2030, representing a compound annual growth rate (CAGR) of 2.4% during the forecast period from 2023 to 2030. This growth trajectory is underpinned by various factors, including the ongoing COVID-19 pandemic and geopolitical events like the Russia-Ukraine conflict, which have shaped market dynamics.
Market Overview:
The Adult Hemoglobinopathy Testing Market is witnessing remarkable growth due to the surging prevalence of hemoglobin disorders and the growing demand for precise diagnostic solutions. Hemoglobinopathies encompass a group of genetic disorders characterized by abnormal hemoglobin production or structure, including conditions such as sickle cell diseas...